Structural proteomics - a new driving force in drug discovery

From the identification of first inhibitors to lead optimisation, having access to high-resolution protein structures is a key advantage in the search for new therapeutic agents.

Judd Berman, Christian Burks, Raymond Hui and Molly B Schmid, Affinium Pharmaceuticals, Inc (June 2004)

Keywords: high-resolution protein structures, drug discovery, structural proteomics, structural genomics,

View full article    |    Back to Discovery Technology section